Programme

Welcome Speech

Accelerated approaches for interrogating cancer drivers and dependencies in the mouse

• Professor Scott Lowe
  

Mechanisms that generate antibody repertoires and their roles in genome stability and cancers of the adaptive immune system

• Professor Frederick Alt Harvard Medical School
  

Targeting cancer with synthetic lethality

• Professor Alan Ashworth University of California, San Francisco
  

Multiple mechanisms of HBx in promoting chromosome instability

• Dr Wilson Ching HKU
  

Oral presentations

Epigenetics stochasticity in normal development and cancer

• Professor Andrew Feinberg Johns Hopkins University
  

PRMT6-dependent CRAF/ERK signalling regulates cancer stem cell plasticity in liver cancer

• Dr Ma Stephanie HKU
  

Poster session

The multiple roles of cancer-associated fibroblasts

• Dr Erik Sahai
  

Stearoyl-CoA Desaturase regulates sorafenib resistance via modulation of ER stress induced differentiation

• Dr Lee Terence Hong Kong Polytechnic University
  

Oral presentations

Immunotherapy: The fourth pillar of cancer treatment

• Professor Tak Mak University of Toronto
  

Delineating epigenetic alterations in liver cancer

• Dr Wong Jack HKU
  

Poster session

Opening address

Tumor suppressor and tumor maintenance genes

• Professor Scott Lowe
  

Recurrent DNA break cluster genes in neural stem and progenitor cells: Implications for brain development, neuropsychiatric disease and cancer

• Professor Frederick Alt Harvard Medical School
  

Targeting cancer with synthetic lethality

• Professor Alan Ashworth University of California, San Francisco
  

Epigenetics at the crossroad of genetics and environment leading to disease

• Professor Andrew Feinberg Johns Hopkins University
  

Imaging therapy failure

• Dr Erik Sahai
  

Cancer Metabolism: Back to the future

• Professor Tak Mak University of Toronto
  

Closing Remarks